Daiichi Sankyo
Katy May is a seasoned professional in clinical study management with extensive experience at Daiichi Sankyo, Inc. since October 2015, progressing from Clinical Study Associate to Sr. Clinical Study Manager. Prior experience includes roles at PAREXEL from January 2013 to September 2015, where responsibilities encompassed live study management and client liaison, and at PRA International as Project Associate II from January 2011 to January 2013, focusing on project document management and planning. Additionally, Katy served as a Fraud Reporting & Project Analyst at ING DIRECT, delivering security operations reporting to executive members. Katy holds a Bachelor of Arts in History from the University of Connecticut, earned in 2007.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.